- 新光药业 (300519)- 非流动负债

  1. 首 页
  2. 新光药业
  3. 非流动负债

按负债周期分类：一年以上到期的非流动负债分析

归母股东权益
8.1亿    ,7.1,7.5,8.0,8.3,8.5,8.6,8.4,8.1
了解明细
少数股东权益
0亿    ,0,0,0,0,0,0,0,0
了解明细
负债合计
0.8亿    ,0.7,0.7,0.6,0.6,0.9,1.0,0.9,0.8
了解明细
资产合计
8.8亿    ,7.8,8.2,8.6,8.9,9.3,9.6,9.3,8.8
了解明细



流动负债
0.7亿    ,0.6,0.6,0.5,0.5,0.8,0.9,0.8,0.7
7.9%
了解明细
非流动负债
0.1亿    ,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1
1.1%
了解明细



长期借款
0亿    ,0,0,0,0,0,0,0,0
了解明细
应付债券
0亿    ,0,0,0,0,0,0,0,0
了解明细
长期应付款
0.0亿    ,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
了解明细
专项应付款
0亿    ,0,0,0,0,0,0,0,0
了解明细
预计负债
0亿    ,0,0,0,0,0,0,0,0
了解明细
递延所得税负债
0亿    ,0.0,0.0,0.0,0.0,0.0,0.0,0,0
了解明细
递延收益-非流动负债
0.1亿    ,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1
了解明细
其他非流动负债
0亿    ,0,0,0,0,0,0,0,0
了解明细
资产负债表排雷 资产成长性分析 资产营运能力分析 资产质量分析 财务安全分析

通过 新光药业 负债的周期分类（按距离到期一年为界限）：一类为流动负债，是距离到期一年内的负债；一类非流动负债，是距离到期一年以上的负债。流动负债与流动资产是密切相关的，通过两者的比较可以大致了解企业的短期偿债能力和清算能力。